United Therapeutics (UTHR) return on invested capital (ROIC)

Return on invested capital · fiscal 2024
22.3%

United Therapeutics (UTHR) earned a return on invested capital of 22.3% in fiscal 2024 (the year ended December 31, 2024). That is 5.6 percentage points higher than the 16.7% of fiscal 2023. Figures as of 17 Nov 2026, 23:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on invested capital, fiscal 2024
22.3%
Change on fiscal 2023
+5.6 pts
Highest on record
22.3%fiscal 2024
Lowest on record
16.2%fiscal 2022
Fiscal years on record
32022–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

United Therapeutics return on invested capital (ROIC), in more detail

Across the 3 fiscal years on record (2022–2024), the highest was 22.3% in fiscal 2024 and the lowest 16.2% in fiscal 2022.

History · 3 fiscal years

Return on invested capital by fiscal year

United Therapeutics return on invested capital (ROIC), year by year

United Therapeutics (UTHR) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
202422.3% 5.6 pts up
202316.7% 0.5 pts up
202216.2%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of United Therapeutics and comparable companies
CompanyReturn on invested capitalFiscal year
STERIS STE9.4%2026
United Therapeutics UTHR22.3%2024
Incyte INCY63.8%2025
Viatris VTRS0.7%2025
Tenet Healthcare THC20.0%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on UTHR

United Therapeutics, figure by figure

United Therapeutics (UTHR) overview: price, valuation and scorecardAll health care companies by market value

United Therapeutics return on invested capital (ROIC): questions and answers

What is United Therapeutics's return on invested capital?

United Therapeutics (UTHR) earned a return on invested capital of 22.3% in fiscal 2024 (the year ended December 31, 2024). That is 5.6 percentage points higher than the 16.7% of fiscal 2023.

What are the highest and lowest return on invested capital figures on record for United Therapeutics?

Across the 3 fiscal years on record (2022–2024), the highest was 22.3% in fiscal 2024 and the lowest 16.2% in fiscal 2022.

How is United Therapeutics's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “United Therapeutics (UTHR) return on invested capital (ROIC)”, data as of 17 November 2026. https://funkfolio.com/stock/UTHR/roic

Underlying data: the company's filings with the SEC and Yahoo Finance.